|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.190 USD | +3.30% |
|
+20.33% | +46.98% |
| 11-14 | Marker Therapeutics Q3 net loss narrows to $2 mln | RE |
| 11-13 | Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 2.19 | 2.19 | 2.774 |
| Spread/Res. | -0.00% | -0.00% | -21.06% |
| Spread/Supp. | +31.14% | +73.81% | +71.09% |
| Support | 1.67 | 1.26 | 1.28 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MRKR Stock
- Charts Marker Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition